If we really want to make some contribution, I propose the U of Penn dermatology department… specifically Follica. I, like Benji, really don’t understand why this technology isn’t getting the hype that ICX was getting. IMO ICX is like beating a dead horse.
After reading… no wading through the patent for Follica, it seems the only reason for a long period of trials is… which wnt protein will inhibit the signaling of HF(hair follicle) creation or neogenesis. By wounding the epidermis a precursor cell such as epidermal stem cells, dermal papilla cells, epithelial cells, etc. must be activated.
The key here is getting the right protein be it nucleotide encoding an EGF protein or EGF receptor to inhibit all this cell activity by means of some sort of b-catena protein or encoding a Hedgehog protein(??? WTF do I know).
I know this is just a brief synopsis but the point here is I think this will work and the science creates brand new HF. If we pour our efforts ($$$) into this technology maybe at least we can bring it to market sooner than “5 years”.